Dermata Therapeutics, Inc. (DRMA) Financials
DRMA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 7.5 million | 1.1 million |
| Dec. 31, 2025 | 7.9 million | 1.6 million |
| Sept. 30, 2025 | 5.1 million | 1.1 million |
| June 30, 2025 | 6.6 million | 1.0 million |
DRMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -2.5 million | 43278 |
| Dec. 31, 2025 | -1.3 million | 29469 |
| Sept. 30, 2025 | -1.8 million | 37841 |
| June 30, 2025 | -2.7 million | 39233 |
DRMA Net Income
No data available :(
DRMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 6.9 million | - | - |
| Dec. 31, 2025 | 7.5 million | - | - |
| Sept. 30, 2025 | 4.7 million | - | - |
| June 30, 2025 | 6.5 million | - | - |
DRMA Shares Outstanding
DRMA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 383724 | 1.5 million | - |
| Dec. 31, 2025 | 3 | 526620 | 1.4 million | - |
| Sept. 30, 2025 | 5 | 504387 | 1.3 million | 472940 |
| June 30, 2025 | - | 617835 | 1.2 million | - |
DRMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | - |
DRMA
Price: $1.32
52 week price:
Earnings Per Share: -4.14 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 329600
Market Capitalization: 913286